Proteomics

Dataset Information

0

Proteome dynamics of HL-60, NB4, and K562 cells under the ATRA treatment

ABSTRACT: Searching for new strategies of acute myeloid leukemia (AML) treatment is of particular interest. Cell lines, e. g. HL-60 and NB4, represent model systems to study molecular features of leukemic cells. The all-trans-retinoic acid (ATRA) has proven itself to be an effective treatment for one of AML subtypes, i.e., acute promyelocytic leukemia (APL). At the same time, ATRA causes granulocytic differentiation of non-APL leukemic cells in vitro. Combination of new therapeutics with ATRA could improve efficiency of treatment. Studying the proteome perturbation in leukemic cells under the ATRA treatment allows to determine potential regulatory molecules that could be affected pharmacologically. Thus, the TMT-based proteomic profiles of HL-60, NB4, and K562 cell lines under the ATRA treatment were obtained at 0, 3, 12, 24, and 72 h after the ATRA treatment.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell, Blood

DISEASE(S): Acute Leukemia

SUBMITTER: Svetlana Novikova  

LAB HEAD: Victor Zgoda

PROVIDER: PXD050317 | Pride | 2024-06-23

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
270122RNF_NSE_TMT01.raw Raw
270122RNF_NSE_TMT01_20220127185110.raw Raw
270122RNF_NSE_TMT01_20220127202428.raw Raw
270122RNF_NSE_TMT01_20220127215747.raw Raw
270122RNF_NSE_TMT01_20220127233105.raw Raw
Items per page:
1 - 5 of 33
altmetric image

Publications

Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia.

Novikova Svetlana S   Tolstova Tatiana T   Kurbatov Leonid L   Farafonova Tatiana T   Tikhonova Olga O   Soloveva Natalia N   Rusanov Alexander A   Zgoda Victor V  

International journal of molecular sciences 20240423 9

Combining new therapeutics with all-<i>trans</i>-retinoic acid (ATRA) could improve the efficiency of acute myeloid leukemia (AML) treatment. Modeling the process of ATRA-induced differentiation based on the transcriptomic profile of leukemic cells resulted in the identification of key targets that can be used to increase the therapeutic effect of ATRA. The genome-scale transcriptome analysis revealed the early molecular response to the ATRA treatment of HL-60 cells. In this study, we performed  ...[more]

Similar Datasets

Transcriptomics Gene expression profiling of ATRA-differentiated wild-type and TG2 knockout NB4 cells
2010-12-01 | E-GEOD-23702 | biostudies-arrayexpress
Genomics Chromatin accessibility, p300 and histone acetylation define PML-RARalpha- and AML1-ETO-binding sites
2012-08-29 | E-GEOD-30254 | biostudies-arrayexpress
Transcriptomics Transcription profiling of human ATRA treated NB4 cells
2009-12-14 | E-GEOD-19201 | biostudies-arrayexpress
Transcriptomics Expression data from Pin1 inhibitor ATRA and Pin1 knockdown
2015-04-12 | E-GEOD-63059 | biostudies-arrayexpress
Genomics PML-RARa/RXR alters the epigenetic landscape in Acute Promyelocytic Leukemia
2009-12-17 | E-GEOD-18886 | biostudies-arrayexpress
Transcriptomics Gene expression profiling of ATRA-differentiated wild-type and TG2 knockout NB4 cells
2010-12-01 | GSE23702 | GEO
Transcriptomics Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia [Illumina HumanHT-12 gene expression array]
2012-03-14 | E-GEOD-34672 | biostudies-arrayexpress
Genomics Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia [ChIP-Seq]
2012-03-14 | E-GEOD-34725 | biostudies-arrayexpress
Proteomics Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
2018-10-16 | PXD010224 | Pride
Proteomics Nuclear proteomics of induced granulocytic differentiation
2023-03-11 | PXD035281 | Pride